Clearasil Stubborn Acne Control 5in1 Exfoliating Wash

Description

Clearasil® Control 5in1 Exfoliating Wash is formulated to address stubborn acne through the active ingredient salicylic acid, a recognized acne medication. This product targets five specific acne-related issues: blocked pores, pimple size, excess oil, acne marks, and blackheads. The formulation is presented in a liquid dosage form, with a total volume of 6.78 fluid ounces (200 mL).

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

The patient’s face should be wet prior to application. The product should be dispensed into the hands, lathered, and gently massaged onto the face and neck, taking care to avoid the delicate eye area. Rinse thoroughly with warm water.

Initially, it is recommended to start with one application daily to minimize the risk of excessive drying of the skin. Based on individual tolerance and as directed by a healthcare professional, the frequency may be gradually increased to two or three times daily.

In cases where bothersome dryness or peeling occurs, the application frequency should be reduced to once a day or every other day to maintain skin comfort and integrity.

Contraindications

There are no specified contraindications for this product. However, healthcare professionals should advise patients to discontinue use and consult a physician if skin or eye irritation develops.

Contact with the eyes should be avoided; in the event of exposure, the eyes must be rinsed thoroughly with water. The risk of skin irritation and dryness may increase if used concurrently with other topical acne medications; therefore, it is recommended to use only one topical acne medication at a time if irritation occurs. Additionally, the product should be limited to application on the face and neck.

Warnings and Precautions

This product is intended for external use only. Healthcare professionals should advise patients to avoid contact with the eyes. In the event that the product comes into contact with the eyes, it is imperative to rinse thoroughly with water to mitigate potential irritation.

When utilizing this product, it is important to note that the likelihood of skin irritation and dryness may increase if used concurrently with other topical acne medications. Therefore, it is recommended that patients limit the use of topical acne treatments to one at a time to minimize the risk of adverse effects. Additionally, the application should be restricted to the face and neck areas only.

Patients should be instructed to discontinue use and consult a healthcare provider if any skin or eye irritation develops. It is crucial to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center should be made without delay.

Side Effects

Patients using this product should be aware that it is intended for external use only. Contact with the eyes should be avoided; in the event that the product comes into contact with the eyes, it is recommended to rinse thoroughly with water.

Skin irritation and dryness are common adverse reactions, particularly if the product is used concurrently with other topical acne medications. To minimize the risk of irritation, it is advised that patients limit the use of topical acne treatments to one product at a time.

Patients should discontinue use and consult a healthcare professional if they experience skin or eye irritation. Additionally, this product should be kept out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought or contact with a Poison Control Center is recommended.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications is recommended to allow the skin to recover. Monitoring for signs of irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Clearasil Stubborn Acne Control 5in1 Exfoliating Wash (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be monitored closely to ensure the medication is kept out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

For topical application, it is recommended to initiate treatment with one application daily. Depending on the patient's response and as directed by a healthcare professional, the frequency may be gradually increased to two or three times daily. Care should be taken to observe for excessive drying of the skin; if bothersome dryness or peeling occurs, the application frequency should be reduced to once daily or every other day.

Geriatric Use

There is no specific information regarding the use of Clearasil Stubborn Acne Control 5in1 Exfoliating Wash in geriatric patients. The drug insert does not provide details on dosage adjustments, safety concerns, or special precautions that may be necessary for elderly patients. Therefore, healthcare providers should exercise caution and consider individual patient factors when recommending this product to geriatric patients, as the absence of specific data necessitates careful monitoring and assessment of treatment efficacy and safety in this population.

Pregnancy

The safety of this product during pregnancy has not been established. Salicylic acid is contraindicated in pregnancy due to potential risk to the fetus. The use of salicylic acid during pregnancy may pose risks, and it is advised that pregnant patients consult a healthcare provider before use. Additionally, dosage adjustments may be necessary for pregnant individuals; therefore, healthcare professionals should be consulted for guidance on appropriate dosing.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication. It is advisable to monitor breastfed infants for any potential effects, although no specific concerns have been identified in the available information.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise caution and consider the lack of data when prescribing this medication to patients with liver problems.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should be contacted without delay. It is recommended to reach out to a Poison Control Center for expert guidance on managing the situation effectively.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Healthcare providers should be prepared to assess the patient's condition and implement appropriate management strategies based on the severity of symptoms and the specific substance involved.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Reports of side effects have been received through voluntary submissions and surveillance programs. Individuals are encouraged to report any adverse events to the designated phone number provided for this purpose.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children and to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed.

Patients should be instructed to stop using the product and consult a doctor if they experience any skin or eye irritation. It is important to emphasize that while using this product, patients must avoid contact with the eyes. In the event that the product does come into contact with the eyes, they should rinse thoroughly with water.

Additionally, healthcare providers should inform patients that skin irritation and dryness may be more likely to occur if they are using another topical acne medication concurrently. Therefore, if irritation develops, patients should limit their use to one topical acne medication at a time. Finally, patients should be reminded to restrict the application of the product to the face and neck only.

Storage and Handling

The product is supplied in a tightly closed container to ensure its integrity. It should be stored in a cool, dry place to maintain optimal conditions. Proper handling is essential to preserve the quality of the product.

Additional Clinical Information

The product is administered topically, with a recommended frequency of rinsing thoroughly with warm water one to three times daily. Clinicians should advise patients to avoid contact with the eyes; in the event of contact, patients should rinse thoroughly with water.

Patients are cautioned that skin irritation and dryness may be exacerbated by concurrent use of other topical acne medications, and it is recommended to limit application to the face and neck. If skin or eye irritation develops, patients should discontinue use and consult a healthcare professional. Should bothersome dryness or peeling occur, patients may reduce the frequency of application to once daily or every other day.

Drug Information (PDF)

This file contains official product information for Clearasil Stubborn Acne Control 5in1 Exfoliating Wash, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)